Core Laboratories NV (CLB)
Official siteENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE
Market Cap: $417.45M
Last updated: Nov 17, 2026 at 11:04 AM ET
Core Laboratories NV (CLB) Financials: Revenue, Profit and Cash Flow
Core Laboratories NV reported revenue of $526.52M for the fiscal year ended Dec 31, 2025, up 0.5% from the year before. That year, net income was $29.67M with a net margin of 5.6%, operating cash flow was $37.03M and free cash flow was $22.29M. The quarter ended Sep 30, 2026 had revenue of $132.08M and net income of $5.44M.
Revenue and Margins
The operating margin was 9.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $594.74M, a compound annual decline of 1.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $526.52M | +0.5% | 17.9% | 9.6% | 5.6% |
| Dec 2024 | $523.85M | +2.8% | 16.9% | 11.2% | 6.0% |
| Dec 2023 | $509.79M | +4.1% | 18.4% | 10.7% | 7.2% |
| Dec 2022 | $489.74M | +4.1% | 16.1% | 8.5% | 4.0% |
| Dec 2021 | $470.25M | -3.5% | 17.8% | 9.6% | 4.2% |
| Dec 2020 | $487.27M | -27.1% | 21.0% | -15.8% | -20.0% |
| Dec 2019 | $668.21M | -4.7% | 25.8% | 14.5% | 15.3% |
| Dec 2018 | $700.85M | +6.2% | 25.8% | 16.9% | 11.3% |
| Dec 2017 | $659.81M | +10.9% | 24.3% | 17.0% | 12.6% |
| Dec 2016 | $594.74M | N/A | 21.1% | 14.5% | 10.7% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 5.5% from the year before. In the quarter ended Sep 2026, net income fell 61.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $526.52M | $523.85M | $509.79M | $489.74M | $470.25M | $487.27M | $668.21M | $700.85M | $659.81M | $594.74M |
| Cost of revenue | $432.24M | $435.48M | $415.74M | $410.82M | $386.41M | $385.14M | $495.58M | $520.05M | $499.18M | $469.52M |
| Gross profit | $94.28M | $88.37M | $94.05M | $78.92M | $83.84M | $102.13M | $172.63M | $180.79M | $160.63M | $125.22M |
| Operating income | $50.49M | $58.56M | $54.64M | $41.52M | $45.26M | -$76.81M | $96.68M | $118.62M | $112.44M | $86.18M |
| Net income | $29.67M | $31.40M | $36.67M | $19.45M | $19.73M | -$97.64M | $101.98M | $79.53M | $83.13M | $63.90M |
| EBITDA | $71.12M | $73.51M | $70.42M | $58.69M | $63.78M | $70.49M | $124.62M | $141.71M | $134.49M | $113.05M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $132.08M | $124.61M | $121.80M | $138.25M | $134.52M | $130.16M | $123.58M | $129.24M | $134.40M | $130.58M | $129.64M | $128.21M |
| Gross profit | $23.26M | $23.24M | $19.72M | $25.07M | $26.03M | $22.79M | $20.40M | $19.37M | $23.92M | $23.88M | $21.21M | $26.69M |
| Operating income | $11.99M | $9.15M | $1.89M | $16.07M | $20.93M | $15.29M | $4.42M | $14.17M | $19.80M | $16.01M | $8.57M | $14.58M |
| Net income | $5.44M | $5.96M | -$789.00K | $4.95M | $14.24M | $10.64M | -$154.00K | $7.40M | $11.74M | $9.03M | $3.22M | $2.20M |
Balance Sheet
As of Dec 2025, total debt of $121.71M exceeded cash and equivalents by $99.01M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $584.01M | $590.41M | $586.39M | $578.35M | $580.85M | $568.58M | $774.67M | $648.83M | $584.81M | $573.05M |
| Current assets | $214.66M | $226.61M | $223.14M | $211.70M | $189.06M | $165.85M | $221.24M | $230.98M | $207.43M | $186.46M |
| Cash and equivalents | $22.70M | $19.16M | $15.12M | $15.43M | $17.70M | $13.81M | $11.09M | $13.12M | $14.40M | $14.76M |
| Total liabilities | $311.80M | $332.67M | $356.59M | $389.40M | $419.85M | $493.01M | $592.53M | $487.93M | $436.08M | $417.75M |
| Short-term debt | $11.46M | $10.69M | $10.18M | $11.70M | $12.34M | $11.44M | $11.84M | $10.40M | $17.07M | $15.69M |
| Long-term debt | $110.25M | $126.11M | $163.13M | $172.39M | $188.64M | $259.43M | $305.28M | $289.77M | $226.99M | $216.49M |
| Shareholder equity | $265.99M | $251.99M | $224.81M | $184.26M | $156.45M | $71.51M | $177.87M | $160.90M | $148.73M | $155.30M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $593.52M | $586.78M | $587.73M | $584.01M | $591.36M | $602.11M | $591.52M | $590.41M | $600.47M | $597.80M | $587.95M | $586.39M |
| Total liabilities | $309.43M | $308.01M | $312.58M | $311.80M | $313.97M | $334.81M | $332.16M | $332.67M | $344.05M | $352.11M | $350.53M | $356.59M |
| Cash and equivalents | $21.38M | $22.73M | $22.82M | $22.70M | $25.63M | $31.19M | $22.11M | $19.16M | $21.47M | $17.70M | $14.91M | $15.12M |
| Shareholder equity | $277.97M | $272.67M | $268.89M | $265.99M | $271.35M | $261.28M | $253.39M | $251.99M | $250.74M | $240.27M | $232.16M | $224.81M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 60.2% of operating cash flow. Dividends came to 8.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $37.03M | $56.39M | $24.79M | $24.96M | $36.58M | $57.87M | $89.53M | $111.83M | $124.27M | $131.89M |
| Capital expenditures | $14.74M | $13.03M | $10.58M | $10.22M | $13.54M | $11.88M | $22.27M | $21.74M | $18.77M | $11.70M |
| Free cash flow | $22.29M | $43.36M | $14.21M | $14.74M | $23.04M | $45.99M | $67.26M | $90.09M | $105.50M | $120.18M |
| Dividends paid | $1.87M | $1.88M | $1.87M | $1.85M | $1.83M | $12.45M | $97.57M | $97.25M | $97.14M | $95.14M |
| Investing cash flow | -$2.23M | -$6.39M | -$6.65M | -$3.86M | -$10.22M | $7.85M | -$5.68M | -$70.64M | -$20.56M | -$14.72M |
| Financing cash flow | -$31.25M | -$45.96M | -$18.45M | -$23.38M | -$22.46M | -$63.01M | -$85.87M | -$42.47M | -$104.08M | -$124.90M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.97M | $7.81M | $3.96M | $7.95M | $8.50M | $13.92M | $6.66M | $20.61M | $13.10M | $17.15M | $5.53M | $19.43M |
| Capital expenditures | $10.66M | $5.77M | $4.89M | $3.80M | $3.03M | $4.33M | $3.58M | $4.38M | $2.73M | $2.87M | $3.06M | $2.58M |
| Free cash flow | -$5.69M | $2.04M | -$926.00K | $4.15M | $5.47M | $9.60M | $3.08M | $16.23M | $10.37M | $14.28M | $2.48M | $16.85M |
Frequently Asked Questions About CLB
What is Core Laboratories NV's annual revenue?
Core Laboratories NV reported revenue of $526.52M for the fiscal year ended Dec 31, 2025.
How fast is Core Laboratories NV's revenue growing?
Revenue was up 0.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.4%.
Is Core Laboratories NV profitable?
Yes. Core Laboratories NV reported net income of $29.67M for the fiscal year ended Dec 31, 2025, with a net margin of 5.6%.
How much free cash flow does CLB generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $37.03M minus capital expenditures of $14.74M produced free cash flow of $22.29M.
How much debt does Core Laboratories NV have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $110.25M, short-term debt of $11.46M and cash and equivalents of $22.70M.
CLB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors